EML:NASDAQEastern Company (The) Analysis
Data as of 2026-03-31 - not real-time
$19.99
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading just above its 20‑day SMA, which sits above the 50‑day SMA but remains below the 200‑day SMA, indicating short‑term strength within a longer‑term downtrend. Momentum is flat, with the RSI hovering near the midpoint and the MACD histogram turning negative, signaling a bearish tilt. Volume has been slipping, adding pressure to the price action. The market respects a support zone in the high‑teens and a resistance ceiling in the low‑twenties, placing the price in a tight range. Volatility is elevated, while beta is comfortably below one, suggesting limited correlation with broader market moves. Overall, the technical picture is neutral to slightly bearish, with downside bias from weakening momentum.
Fundamentally, revenue contracted by double digits year‑over‑year, and margins sit in the low‑20s for gross and single‑digit territory for operating profit. The company trades at a forward PE well below the industry average and a price‑to‑book under one, implying a valuation discount. Free cash flow remains positive and the dividend yield exceeds two percent, backed by a payout ratio under half of earnings, supporting dividend sustainability. Debt levels are moderate, with a debt‑to‑equity ratio in the low‑forties percent range, and cash on hand is modest but sufficient to cover near‑term obligations. Management highlighted a leaner cost structure, signs of demand stabilization for 2026, and a strengthening balance sheet during the recent earnings call. Recent insider purchases, albeit small, add a modest confidence signal, making the stock a potential value‑oriented play for investors comfortable with short‑term volatility.
Fundamentally, revenue contracted by double digits year‑over‑year, and margins sit in the low‑20s for gross and single‑digit territory for operating profit. The company trades at a forward PE well below the industry average and a price‑to‑book under one, implying a valuation discount. Free cash flow remains positive and the dividend yield exceeds two percent, backed by a payout ratio under half of earnings, supporting dividend sustainability. Debt levels are moderate, with a debt‑to‑equity ratio in the low‑forties percent range, and cash on hand is modest but sufficient to cover near‑term obligations. Management highlighted a leaner cost structure, signs of demand stabilization for 2026, and a strengthening balance sheet during the recent earnings call. Recent insider purchases, albeit small, add a modest confidence signal, making the stock a potential value‑oriented play for investors comfortable with short‑term volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- Decreasing volume trend
- Price confined between support and resistance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Management guidance on demand stabilization
- Undervalued valuation multiples
- Sustainable dividend yield
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low beta and defensive profile
- Value‑oriented valuation discount
- Consistent dividend with sustainable payout
Key Metrics & Analysis
Financial Health
Revenue Growth-13.70%
Profit Margin2.86%
P/E Ratio20.4
ROE4.86%
ROA3.65%
Debt/Equity43.21
P/B Ratio1.0
Op. Cash Flow$8.9M
Free Cash Flow$3.4M
Industry P/E28.1
Technical Analysis
TrendNeutral
RSI53.4
Support$17.66
Resistance$21.45
MA 20$19.88
MA 50$19.05
MA 200$21.17
MACDBearish
VolumeDecreasing
Fear & Greed Index72.23
Valuation
GradeUndervalued
TypeValue
Dividend Yield2.21%
Risk Assessment
Beta0.65
Volatility34.00%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.